Takeda Pharmaceutical Co logo

4502 - Takeda Pharmaceutical Co Share Price

¥4421 -16.0  -0.4%

Last Trade - 6:00am

Sector
Healthcare
Size
Large Cap
Market Cap £48.24bn
Enterprise Value £79.45bn
Revenue £20.08bn
Position in Universe 11th / 3861
Bullish
Bearish
Unlock 4502 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4502 Revenue Unlock 4502 Revenue

Net Income

4502 Net Income Unlock 4502 Revenue

Normalised EPS

4502 Normalised EPS Unlock 4502 Revenue

PE Ratio Range

4502 PE Ratio Range Unlock 4502 Revenue

Dividend Yield Range

4502 Dividend Yield Range Unlock 4502 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4502 EPS Forecasts Unlock 4502 Revenue
Profile Summary

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated January 29, 1925
Public Since May 16, 1949
No. of Shareholders: 327,577
No. of Employees: 49,578
Sector Healthcare
Industry Pharmaceuticals
Index Nikkei 225 , Nikkei 300 ,
Exchange Tokyo Stock Exchange
Shares in Issue 1,557,746,622
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4502 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4502
Upcoming Events for 4502
Thursday 30th January, 2020 Estimate
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Release
Tuesday 4th February, 2020
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call (Japanese)
Tuesday 4th February, 2020
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call
Tuesday 4th February, 2020
Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session
Monday 30th March, 2020
Dividend For 4502.T
Tuesday 12th May, 2020 Estimate
Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Release
Friday 26th June, 2020 Estimate
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting
Similar to 4502
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.